Image of Pardeep Jhund

Professor Pardeep Jhund. 'AZ Statistical Analyses DAPA-HF', Astrazeneca (UK), £76207

250px

Professor Paul Welsh. 'Obesity and cardiovascular disease - UK Biobank' Astrazeneca (UK), £66921

250px

Professor Naveed Sattar. 'BI Consultancy' Boehringer Ingelheim £35880

Professor Naveed Sattar 'Speaker on Expert tour Diabetes NL, EM-0000121725' Boehringer Ingelheim B.V. (Netherland) £9145

Professor Naveed Sattar 'advice on recent scientific disclosures regarding Tirzepatide' Eli Lilly and Company (UK) £1840

Amended

Professor Mark Petrie. 'HERMES: Effects of ziltivekimab versus placebo on morbidity and mortality in patients with heart failure with mildly reduced or preserved ejection fraction and systemic inflammation.' Novo Nordisk (UK), £35638

Professor Mark Petrie. 'A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of LY3540378 in Adults with Worsening Chronic Heart Failure with Preserved Ejection Fraction (HFpEF)' Eli Lilly and Company (UK), £33250

Professor Mark Petrie 'The role of SGLT2i in the peri-discharge phase of patients admitted with acute decompensated heart failure' AstraZeneca - Israel £1575

Prof John McMurray Profile Picture

Professor John McMurray 'Member of Data Monitoring for D432500010 study' WCG Clinical, Inc. £24440

Professor John McMurray 'Member of Steering Committee for dal-GenE-2 study' DalCor Pharmaceuticals Canada Inc. £21797

Professor John McMurray 'Provide expert advice related to AZD9977 Dapagliflozin clinical development (CR-028910)' Astrazeneca (UK) £6000

Professor John McMurray 'Develop and support the DAPA-CKD trial publication plan (CR-023797)' Astrazeneca (UK) £3000

Profile pic 250x330px

Professor Jesse Dawson 'Andexanet alfa development program (CR-028801)' Astrazeneca (SE) £15000

Professor Jesse Dawson 'Andexanet alfa development program (CR-028801)' Medtronic Limited £495

Paddy Mark Profile

Professor Patrick Mark 'Attendance at Global MK-2060 Ph3 Studies Scientific Input Engagement (14/9/23)' Merck (US) £6000

profile 190px

Professor Colin Berry 'Expertise in the area of cardiology, specifically Chronic Myocardial Ischemic Syndrome.' Liberum Independent Medical Education UK £1500

Professor Colin Berry 'Morbidity of heart failure patients post AMI/STEMI' Radcliffe Group Limited £441

 

Professor John Cleland '3-stage modified Delphi panel about iron deficiency diagnosis and management in the UK' Vifor Pharma (UK) £1650


First published: 3 March 2020